CRT devices

Our groundbreaking research has allowed us to develop the world’s longest lasting Cardiac resynchronization therapy defibrillators and SonR, the world’s first and only AV/VV optimization algorithm based on cardiac contractility leading to a 35% risk reduction of HF hospitalization, just a few examples of our commitment to product innovation.

Healthcare Professionals Cardiac Rhythm Management CRT devices

Reply™ CRT-P

Our groundbreaking research has allowed us to develop the world’s smallest Cardiac resynchronization therapy pacemaker 1

Features

  • Sleep Apnea Monitoring: Early detection, lifetime monitoring. SAM allows you to screen patients for severe sleep apnea as well as monitor the evolution of the disease.
  • Dual Sensor: Need for accurate Rate Response in CRT. Exercise is proven to have positive effects on mortality, morbidity and quality of life for CRT patients.2,3,4

This product is not available for sale or distribution in the USA.

Reply CRT P Micro Port 2018

Platinium™ 4LV SonR™ CRT-D

Platinium™ 4LV SonR™ CRT-D gives every patient a chance to become a responder thanks to multiple therapeutic options and features the world’s longest projected longevity.2

Features

  • SonR™: World's only contractility sensor for automatic CRT optimization. 35% risk reduction in heart failure hospitalization.6
  • Parad+™: World’s first dual-chamber discrimination algorithm. Best in class 99% specificity.3
  • BTO™: Unlock Brady and Tachy therapies in the slow VT zone. 96% specificity in slow VT zone.4
  • Multipoint Pacing™: Optimize resynchronization therapy for non-responding heart failure patients.5

This product is not available for sale or distribution in the USA.

PLATINIUM 4 LV SONR 1844 Micro Port front

Platinium™ 4LV CRT-D

Platinium™ 4LV CRT-D is small in design with no compromise on longevity: it features the world's longest projected longevity.2

Features

  • Parad+™: World’s first dual-chamber discrimination algorithm. Best in class 99% specificity.3
  • BTO™: Unlock Brady and Tachy therapies in the slow VT zone. 96% specificity in slow VT zone.4
  • Multipoint Pacing™: Optimize resynchronization therapy for non-responding heart failure patients.5

Caution: Federal law (USA) restricts this device to sale by or on the order of a physician.

PLATINIUM 4 LV CRT D 1744 Micro Port front

MICROPORT® CRM Manuals http://www.microportmanuals.com/

Availability of select products and their functions vary by country. Please check with your representative for further information.

Platinium 4LV CRT-D

  1. Competition comparison made as of March 2020, refer to manufacturers manuals and Boston Scientific longevity calculator available online.
  2. Applicable conditions: A, RV, LV=2.5V; 0.4ms; 500ohms; 100% (15% A pacing for Medtronic Cobalt/Crome); BiV; 60 bpm; Sensor ON (OFF for Abbott Gallant, Biotronik Acticor 7, Rivacor 3/5/7, Medtronic Cobalt/Crome); CRT optimization system OFF; Remote ON; RF telemetry 1-2h at implant and 15-60 min p.a.; 2 battery charges p.a. for capacitor maintenance (1 every 9 months + 4 at implant for Gallant).
  3. Hintringer F, Deibl M, Berger T, Pachinger O, Roithinger FX. Comparison of the specificity of implantable dual chamber defibrillator detection algorithms. Pacing Clin Electrophysiol. 2004;27(7):976-982.
  4. Sadoul N, Mletzko R, Anselme F, et al. Incidence and clinical relevance of slow ventricular tachycardia in implantable cardioverter-defibrillator recipients: an international multicenter prospective study. Circulation. 2005;112(7):946-953.
  5. Pappone C, Ćalović Ž, Vicedomini G, et al. Improving cardiac resynchronization therapy response with multipoint left ventricular pacing: Twelve-month follow-up study. Heart Rhythm. 2015;12(6):1250-1258.

Platinium 4LV SonR CRT-D

  1. Competition comparison made as of March 2020, refer to manufacturers manuals and Boston Scientific longevity calculator available online. Applicable conditions: A, RV, LV=2.5V; 0.4ms; 500ohms; 100% (15% A pacing for Medtronic Cobalt/Crome); BiV; 60 bpm; Sensor ON (OFF for Abbott Gallant, Biotronik Acticor 7, Rivacor 3/5/7, Medtronic Cobalt/Crome); CRT optimization system OFF; Remote ON; RF telemetry 1-2h at implant and 15-60 min p.a.; 2 battery charges p.a. for capacitor maintenance (1 every 9 months + 4 at implant for Gallant).
  2. Brugada J, Delnoy PP, Brachmann J, et al. Contractility sensor-guided optimization of cardiac resynchronization therapy: results from the RESPOND-CRT trial. Eur Heart J. 2017;38(10):730-738.
  3. Hintringer F, Deibl M, Berger T, Pachinger O, Roithinger FX. Comparison of the specificity of implantable dual chamber defibrillator detection algorithms. Pacing Clin Electrophysiol. 2004;27(7):976-982.
  4. Sadoul N, Mletzko R, Anselme F, et al. Incidence and clinical relevance of slow ventricular tachycardia in implantable cardioverter-defibrillator recipients: an international multicenter prospective study. Circulation. 2005;112(7):946-953.
  5. Pappone C, Ćalović Ž, Vicedomini G, et al. Improving cardiac resynchronization therapy response with multipoint left ventricular pacing: Twelve-month follow-up study. Heart Rhythm. 2015;12(6):1250-1258.

Platinium

  1. Competition comparison made as of March 2020, refer to manufacturers manuals and Boston Scientific longevity calculator available online. Applicable conditions: A, V=2.5V; 0.4ms; 500ohms; 100% (15% A pacing for Medtronic Cobalt/Crome); VVI for VR models / DDD for DR models; 60 bpm (40bpm for Biotronik Acticor 7 VR-T, Rivacor 3/5/7 VR-T); Sensor ON (OFF for Abbott Gallant, Biotronik Acticor 7, Rivacor 3/5/7, Medtronic Cobalt/Crome); Remote ON; RF telemetry 45min-2h at implant and 15-60 min p.a.; 2 battery charges p.a. for capacitor maintenance (1 every 9 months + 4 at implant for Gallant).
  2. Hintringer F, Deibl M, Berger T, Pachinger O, Roithinger FX. Comparison of the specificity of implantable dual chamber defibrillator detection algorithms. Pacing Clin Electrophysiol. 2004;27(7):976-982.
  3. Kolb C, Sturmer M, Sick P, et al. Reduced risk for inappropriate implantable cardioverter-defibrillator shocks with dual-chamber therapy compared with single-chamber therapy: results of the randomized OPTION study. JACC Heart Fail. 2014;2(6):611-619.
  4. Sadoul N, Mletzko R, Anselme F, et al. Incidence and clinical relevance of slow ventricular tachycardia in implantable cardioverter-defibrillator recipients: an international multicenter prospective study. Circulation. 2005;112(7):946-953
Safer

SafeRTM

SafeR allows for intelligent management of AV conduction, significantly reducing unnecessary RV pacing in all pacemaker patients, including AV block patients.1–8

Discover this therapy
Logo Auto MRI circle blue

AutoMRITM

AutoMRI mode is the world’s first pacemaker technology capable of detecting an MRI field and automatically switching to asynchronous mode.

Discover this therapy
Sam

SAMTM

Proactive management of comorbidities. Early detection, long-term risk reduction. 1–6

Discover this therapy
Parad

PARAD+TM

World's first dual-chamber discrimination algorithm.

Discover this therapy
Dual

Dual SensorTM

Twin trace is designed to physiologically modulate the heart rhythm by combining Accelerometer and Minute Ventilation sensors.

Discover this therapy
Sonr

SonRTM

SonR™ measures real-time LV contractilty1 to optimize AV & VV delays.

Discover this therapy
BTO

BTO™

Active resynchronization

Discover this therapy
Multipoint

Multipoint pacing™

Simultaneous Multipoint Pacing™

Discover this therapy

TECH CORNER

PICTO Paper article

SafeR Pacing Mode

Unnecessary ventricular pacing increases the risk of atrial fibrillation and heart failure hospitalization. SafeR is an algorithm found in the current MicroPort dual chamber models and ensures 99,9% intrinsic conduction, significantly reducing unnecessary pacing. SaferTM reduces unnecessary right ventricular pacing in both Sinus Node Disease patients and unselected AV Block patients.

Click here for full article
PICTO Paper article

Dual Sensor

The goal of rate adaptive pacing is to provide an increase in heart rate via an increase in cardiac pacing in response to metabolic needs: this would include during periods of exercise, but also during disease states and emotional reactions. The dual sensor technology is a combination of an accelerometer and minute ventilation for efficient rate response to chronotropic incompetence. It has been designed to blend information from accelerometer and minute ventilation sensors for a more physiologic rate response.

Click here for full article
PICTO Paper article

Rest Rate

Rest Rate is related to rate adaptive pacing. While rate adaptive pacing increases the pacing rate to address patient demands, the rest rate algorithm uses similar data to slow the pacing rate below the programmed basic rate. In this manner, it can reproduce circadian variations without the constraint of being set by a clock schedule. In addition, rest rate has the added benefits of potentially reducing percent pacing and therefore extending battery life, and may offer patients a more physiological pacing rate.

Click here for full article
PICTO Paper article

Sleep Apnea Monitoring (SAM)

With the Sleep Apnea Monitoring (SAM) function, MicroPort pacemakers provide the physician with automatic screening of pacemaker patients for the risk of severe Sleep Apnea. SAM has been designed to detect, count and report abnormal breathing events during the night. These events are detected using the minute ventilation signal. This allows the calculation of respiratory disturbances over the last six months, representing sleep disordered breathing events at night.

Click here for full article
PICTO Paper article

Window of Atrial Rate Acceleration Detection (WARAD)

The WARAD is designed to monitor the atrial activity in order to discriminate pathological atrial waves (Atrial Fibrillation, Atrial Flutter, Atrial Tachycardias) from sinus P waves. This atrial discriminator uses atrial prematurity to trigger mode switching. Refer also to the Fallback Mode Switch Tech Corner article for more details on the Fallback Mode Switch algorithm.

Click here for full article
PICTO Paper article

Fallback Mode Switch

The FMS function is designed to diagnose atrial arrhythmias and manage their occurrence using the WARAD (Window of Atrial Rate Acceleration Detection): in the event of atrial arrhythmia, FMS switches from DDD®, SafeR® or Dplus® pacing mode to an inhibited dual- chamber pacing mode DDI® to avoid prolonged ventricular pacing at a high rate for the entire duration of the sustained atrial arrhythmia.

Click here for full article
PICTO Paper article

Automatic Implantation Detection

Automaticity at Implantation allows the pacemaker to automatically detect if the device is implanted. It has been designed to provide a secure functioning of the device during implantation without prior or post implantation interrogation.

Click here for full article
PICTO Paper article

Anti-PMT (Pacemaker Mediated Tachycardia) algorithm

The Anti-PMT algorithm is intended to protect the patient from Pacemaker-Mediated Tachycardia (PMT) without reducing the atrial sensing capability of the device.

Click here for full article